NCT00515164View on ClinicalTrials.gov

US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

December 31, 2009

Conditions
Pulmonary EmphysemaChronic Obstructive Pulmonary Disease
Interventions
DRUG

Biologic Lung Volume Reduction (BLVR) - 20 mL Hydrogel

20 mL Hydrogel

Trial Locations (8)

19140

Temple University Lung Center, Philadelphia

21204

St Joseph's Medical Center, Towson

29425

Medical University of South Carolina, Charleston

44195

Pulmonary, Allergy & Critical Care Medicine, Cleveland Clinic Foundation, Cleveland

44302

Akron Medical Center, Akron

52242

University of Iowa Hospitals & Clinics, Iowa City

66606

Veritas Clinical Specialties, Ltd, Topeka

85006

Pulmonary Associates, Phoenix

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT00515164 - US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study | Biotech Hunter | Biotech Hunter